{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:37:38Z","timestamp":1767145058978,"version":"build-2238731810"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Entergy Charitable Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.conctc.2019.100327","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T07:03:35Z","timestamp":1548831815000},"page":"100327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A regression based phase I clinical trial for late-onset toxicities without clinician elicitation"],"prefix":"10.1016","volume":"14","author":[{"given":"Andrew G.","family":"Chapple","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-167X","authenticated-orcid":false,"given":"Janusz J.","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5007-0582","authenticated-orcid":false,"given":"Lee S.","family":"McDaniel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.conctc.2019.100327_bib1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2307\/2531693","article-title":"Design and analysis of phase I clinical trials","author":"Storer","year":"1989","journal-title":"Biometrics"},{"key":"10.1016\/j.conctc.2019.100327_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2307\/2531628","article-title":"Continual reassessment method: a practical design for phase 1 clinical trials in cancer","author":"O'Quigley","year":"1990","journal-title":"Biometrics"},{"key":"10.1016\/j.conctc.2019.100327_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2307\/2532905","article-title":"Continual reassessment method: a likelihood approach","author":"O'Quigley","year":"1996","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.conctc.2019.100327_bib4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.0006-341X.2000.01177.x","article-title":"Sequential designs for phase I clinical trials with late-onset toxicities","volume":"56","author":"Cheung","year":"2000","journal-title":"Biometrics"},{"issue":"5","key":"10.1016\/j.conctc.2019.100327_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1740774508096474","article-title":"A comprehensive comparison of the continual reassessment method to the standard 3+ 3 dose escalation scheme in phase i dose-finding studies","volume":"5","author":"Iasonos","year":"2008","journal-title":"Clin. Trials"},{"issue":"3","key":"10.1016\/j.conctc.2019.100327_bib6","first-page":"200","article-title":"Phase 1 trial design: is 3+3 the best?","volume":"21","author":"Hansen","year":"2014","journal-title":"Canc. Contr."},{"issue":"2","key":"10.1016\/j.conctc.2019.100327_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0197-2456(00)00132-X","article-title":"Isotonic designs for phase I trials","volume":"22","author":"Leung","year":"2001","journal-title":"Contr. Clin. Trials"},{"key":"10.1016\/j.conctc.2019.100327_bib8","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2018"},{"key":"10.1016\/j.conctc.2019.100327_bib9","series-title":"Order Restricted Statistical Inference","author":"Robertson","year":"1988"},{"key":"10.1016\/j.conctc.2019.100327_bib10","series-title":"Iso: Functions to Perform Isotonic Regression","author":"Turner","year":"2015"}],"updated-by":[{"DOI":"10.1016\/j.conctc.2020.100690","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865418301509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865418301509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:01:13Z","timestamp":1762520473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865418301509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":10,"alternative-id":["S2451865418301509"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2019.100327","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A regression based phase I clinical trial for late-onset toxicities without clinician elicitation","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2019.100327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100327"}}